eISSN: 1734-4948
ISSN: 0860-6161
Advances in Rehabilitation
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


Advances in Rehabilitation [Adv Rehab] is a scientific journal published continuously since 1987. The journal is addressed to professionals from different fields of rehabilitation such as cardiology, neurology, orthopedics, traumatology, internal medicine or pediatrics. The journal also includes papers concerning psychological, sociological and ethical aspects related to the process of rehabilitation. We publish articles from the fields of medical rehabilitation, physiotherapy, adapted physical activity and occupational therapy.
The journal is published in electronic version (ISSN 0860-6161, eISSN 1734-4948). The editorial team accepts original papers, reviews as well as letters to editor.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journal is cofinanced by the Polish Rehabilitation Society.


The editorial team examines the submitted manuscripts under the following conditions:
a) they have not been published elsewhere – both fully and in their essential parts – in print or electronic media (except in the form of an abstract or a report from a scientific meeting or a conference, whose copies are to be submitted together with the paper);
b) they have not been submitted to the editorial office of other journals;
c) all authors agree on the publication of the presented material;
d) information about the specific contribution that each author made to the manuscript is provided (in order to prevent the practice of “ghostwriting” and “guest authorship”);
e) all sources of financial support for publication are disclosed.
The above information is included in the statement submitted by the first author (Statement Advances in Rehabilitation.doc).

The editorial process starts after the correct version of the manuscript together with necessary attachments is submitted.
Once accepted for publication, the paper becomes the property of Józef Piłsudski University of Physical Education in Warsaw. Thus, any and all copyrights – to publish and distribute the submitted material in any form known – shall be transferred to the publisher. Therefore, the paper may not be published (in whole or in part) by other publishers in Poland or abroad without the publisher’s prior consent.
Manuscripts that do not conform to the editorial rules will be returned for improvement without any content-related analysis.


The manuscript of each paper is subject to review. The reviews are anonymous (“double-blind review process”); at the request of the reviewer their name may be disclosed to the author(s). The reviewers prepare opinions which include justified recommendations and suggestions of changes and supplements to the content and form of the article. The review is in a written form and ends with an approval or rejection of the article.
Based on reviews editorial team makes a decision concerning publication, either:
- Reject – the paper is not acceptable for publication and re-submission will not be considered; or
- Rate manuscript once again after major changes and another review – the paper requires major changes and needs to go through the review process again with no guarantee of acceptance; or
- Accept after changes suggested by reviewer – the paper is provisionally accepted, subject to conditions that need to be addressed in producing a final version of the manuscript; or
- Accept without changes – the paper is accepted without any changes.

The list of reviewers is published once a year on the website of the journal.


The Editor-in-Chief has the right to refuse to print the paper including the results of research during which ethical rules for clinical trials, defined in the declaration of the World Medical Association in Helsinki in 1964 and in Tokyo in 1975, and in the recommendations of the World Health Organization from 1982, have not been complied with.
All experimental studies using human or animal subjects should include an explicit statement in the Material and Methods section identifying the ethics committee approval for each study.

To facilitate proper peer-reviewing of your manuscript, it is essential that it is submitted in grammatically correct English. If you are not a native English speaker, we recommend that you have your manuscript professionally edited before submission or read by a native English-speaking colleague. Professional editing will enable reviewers and future readers to more easily read and assess the content of submitted manuscripts. Authors of manuscripts in polish that are accepted for publication are given two weeks to have their papers translated into English by the translators indicated by the journal editors. The cost of translation and corrections are covered by the authors. There are no article processing charges (APC), submission fees or page charges for this journal.


All manuscripts should be submitted to Editorial Office by electronic Editorial System. The submission, apart from the manuscript, tables and figures, shall include a completed and signed statement. The main responsibility for the included information lies with the author submitting the manuscript.

The total length of the paper including abstracts, tables, figures and references must not exceed: original articles – 3500 words; reviews – 6000 words; letters to the editor – 500 words.

ORIGINAL ARTICLES: All original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information.

REVIEWS: These provide concise and precise updates on the latest progress made in a given area of research. Systematic reviews should follow the PRISMA GUIDELINES - www.prisma-statement.org.

Obligatory information that has to be provided during the submission

- title of the paper, short title (maximum character count: 60), names, surnames and affiliations of all authors;
- abstract built structurally, i.e. including introduction, material and methods, results and conclusions, including, in total, from 200 to 250 words;
- 3-5 key words chosen from the MeSH catalogue (Medical Subject Headings Index Medicushttp://www.nlm.nih.gov/mesh/MBrowser.html). Key words should not duplicate words from the title of the paper;
- sources of financial support available to the research.

The manuscript should be prepared in the following way:

The paper should be written in font Times New Roman normal –12 point, space between the lines – 1.5 point, adjusted text. The title of the article – 14 point, bold; subtitles (Introduction, Results etc.) 12 point, bold, separated from the main text with double-space. Additional formatting elements (e.g. bold, italics, underline) should be avoided in the text.

1. Main text should be divided into the following parts:

- introduction - summary of current knowledge leading to the overall design and purpose of the study;

- materials and methods - clear description of methods applied in the study including subjects, intervention, measurements, data collection procedure and statistics. The International System of Units (SI) and standard abbreviations should be used. Any methods already well described and widely known should not be described in detail and should refer to an appropriate reference. Authors must declare that the experiments reported in the manuscript were performed in accordance with the ethical standards of the Helsinki Declaration and that the participants signed an informed consent form;

- results - this section should rely on tables and figures with a minimum of accompanying text. Titles and legends of tables and figures should allow them to be regarded as self-explanatory. There should be no repetition of data already presented in tables or figures;

- discussion - results of the study should be critically discussed from the point of view of limitations of the research project, method applied, and current knowledge available in the literature. Interpretation of the results is encouraged, while avoiding speculations. The end of the discussion section should present practical implications of the results of the study;

- conclusions - Main findings and novel elements of the results should be summarized in the Conclusions. The authors should refrain from making conclusions about facts not demonstrated by their study;

- references.

2. Tables and figures
- all Figures and Tables should be inserted into the main text close to their first citation and must be numbered following their number of appearance (Fig. 1, Fig. 2, Tab. 1, etc.);
- any formatting in the tables should be avoided;
- figures (charts, photos, pictures) should also be supplied in a separate electronic file in bitmap formats (TIFF, GIF, JPEG, etc.). Bitmap images should be of a resolution of at least 300 dpi. In the appropriate places in the text number and title of the figure should be given;
- a maximum of 6 tables and 4 figures is allowed.

3. Supplementary Material
Additional data and files can be uploaded as "Supplementary Files" during the manuscript submission process. The supplementary files will also be available to the referees as part of the peer-review process. Any file format is acceptable; however, we recommend that common, non-proprietary formats are used where possible.


References should be presented in order of quotation in the text. Papers which has not been published and oral information should not be quoted. Abbreviations of titles of the quoted journals should be compatible with Medline (Index Medicus www.nlm.nih.gov/tsd/serials/lji.html). References used in the text should be numbered with Arabic numerals in square brackets. Internet sources – because of easiness to change or correct texts – should include the date of downloading or checking the file. In relation to the list of authors, if the number of authors of the quoted position exceeds 6, the term “et al.” should be used.

Reference positions should be formatted according to the examples presented below.

Journal articles
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002; 347(4): 284-7.

Supplement to the annual bound volume (volume)
Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002; 42 Suppl 2: S93-9.

Supplement to the number (number)
Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002; 58(12 Suppl 7): S6-12.

Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.

Book edited by (…)
Gilstrap LC, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.

Chapter in the book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

Conference materials
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.


Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 1 p.]. Available from:

Web page
eatright.org [Internet]. Chicago: Academy of Nutrition and Dietetics; c2016 [cited 2016 Dec 27]. Available from: http://www.eatright.org/.

Additional information available at: http://www.nlm.nih.gov/bsd/uniform_requirements.html

The above information is included in the statement submitted by the first author (Statement Advances in Rehabilitation.doc)

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe